Malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysis

Background: Osteosarcoma (OS) usually happens in patients under 20 years old and is notorious for its low survivorship and limb loss. Personalized medicine is a viable approach to increase the efficiency of chemotherapy which is the main prognostic factor for survivorship after surgical treatment. M...

Full description

Saved in:
Bibliographic Details
Main Authors: Hsi-Chieh Lin, Kuei-Hsiang Hsu, Jir-You Wang, Wei-Ming Chen, Yi-Chung Tung, Yu-Ping Su
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664624003073
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850169983337758720
author Hsi-Chieh Lin
Kuei-Hsiang Hsu
Jir-You Wang
Wei-Ming Chen
Yi-Chung Tung
Yu-Ping Su
author_facet Hsi-Chieh Lin
Kuei-Hsiang Hsu
Jir-You Wang
Wei-Ming Chen
Yi-Chung Tung
Yu-Ping Su
author_sort Hsi-Chieh Lin
collection DOAJ
description Background: Osteosarcoma (OS) usually happens in patients under 20 years old and is notorious for its low survivorship and limb loss. Personalized medicine is a viable approach to increase the efficiency of chemotherapy which is the main prognostic factor for survivorship after surgical treatment. Methods: In this five-year prospective observational study, we collected primary cells of osteosarcoma from 15 patients, and examined the correlation between clinical characters of patients and cell properties characterized using various in vitro assays. The properties including genes expression, pro-angiogenic capability and anti-cancer drug response are characterized respectively by using RT-PCR, tube formation assay, osteogenesis assay and drug testing on 3D tumor spheroid model. Result: The results suggest that OS patients with higher MMP9 expression levels have higher probability to develop skip metastasis (p = 0.041). The 3D tumor spheroid test based on the median lethal dose from 2D culture provides some prognostic value. Patients do not response well to methotrexate (MTX) show higher percentage of high pathology grade (p = 0.009) and lung metastasis (p = 0.044). Also, patients respond well to ifosfamide (IFO) have higher probability to achieve high tumor necrosis rate (p = 0.007). Conclusion: The association between cell properties and clinical characters of patients provided by our data can act as potential prognostic factors to help physicians to develop effective personalized chemotherapy for osteosarcoma treatments.
format Article
id doaj-art-8a5eaa79b1b84db3aef4eaf7d7e0be00
institution OA Journals
issn 0929-6646
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj-art-8a5eaa79b1b84db3aef4eaf7d7e0be002025-08-20T02:20:37ZengElsevierJournal of the Formosan Medical Association0929-66462025-07-01124760761510.1016/j.jfma.2024.07.004Malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysisHsi-Chieh Lin0Kuei-Hsiang Hsu1Jir-You Wang2Wei-Ming Chen3Yi-Chung Tung4Yu-Ping Su5Research Center for Applied Sciences, Academia Sinica, Taipei, 11529, TaiwanDepartment of Orthopedic and Traumatology, Taipei Veterans General Hospital, Taipei, 11217, Taiwan; Department of Medicine, National Yang Ming Chiao Tung University, Taipei, 11221, TaiwanDepartment of Orthopedic and Traumatology, Taipei Veterans General Hospital, Taipei, 11217, TaiwanDepartment of Orthopedic and Traumatology, Taipei Veterans General Hospital, Taipei, 11217, Taiwan; Department of Medicine, National Yang Ming Chiao Tung University, Taipei, 11221, TaiwanResearch Center for Applied Sciences, Academia Sinica, Taipei, 11529, TaiwanDepartment of Orthopedic and Traumatology, Taipei Veterans General Hospital, Taipei, 11217, Taiwan; Department of Medicine, National Yang Ming Chiao Tung University, Taipei, 11221, Taiwan; Corresponding author. Department of Orthopedic and Traumatology, Taipei Veterans General Hospital, Taipei, 11217, Taiwan.Background: Osteosarcoma (OS) usually happens in patients under 20 years old and is notorious for its low survivorship and limb loss. Personalized medicine is a viable approach to increase the efficiency of chemotherapy which is the main prognostic factor for survivorship after surgical treatment. Methods: In this five-year prospective observational study, we collected primary cells of osteosarcoma from 15 patients, and examined the correlation between clinical characters of patients and cell properties characterized using various in vitro assays. The properties including genes expression, pro-angiogenic capability and anti-cancer drug response are characterized respectively by using RT-PCR, tube formation assay, osteogenesis assay and drug testing on 3D tumor spheroid model. Result: The results suggest that OS patients with higher MMP9 expression levels have higher probability to develop skip metastasis (p = 0.041). The 3D tumor spheroid test based on the median lethal dose from 2D culture provides some prognostic value. Patients do not response well to methotrexate (MTX) show higher percentage of high pathology grade (p = 0.009) and lung metastasis (p = 0.044). Also, patients respond well to ifosfamide (IFO) have higher probability to achieve high tumor necrosis rate (p = 0.007). Conclusion: The association between cell properties and clinical characters of patients provided by our data can act as potential prognostic factors to help physicians to develop effective personalized chemotherapy for osteosarcoma treatments.http://www.sciencedirect.com/science/article/pii/S0929664624003073OsteosarcomaChemotherapyAngiogenesisOsteogenesisSpheroid modelDrug efficacy
spellingShingle Hsi-Chieh Lin
Kuei-Hsiang Hsu
Jir-You Wang
Wei-Ming Chen
Yi-Chung Tung
Yu-Ping Su
Malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysis
Journal of the Formosan Medical Association
Osteosarcoma
Chemotherapy
Angiogenesis
Osteogenesis
Spheroid model
Drug efficacy
title Malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysis
title_full Malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysis
title_fullStr Malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysis
title_full_unstemmed Malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysis
title_short Malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysis
title_sort malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysis
topic Osteosarcoma
Chemotherapy
Angiogenesis
Osteogenesis
Spheroid model
Drug efficacy
url http://www.sciencedirect.com/science/article/pii/S0929664624003073
work_keys_str_mv AT hsichiehlin malignancyprogressionandtreatmentefficacyestimationofosteosarcomapatientsbasedoninvitrocellculturemodelandanalysis
AT kueihsianghsu malignancyprogressionandtreatmentefficacyestimationofosteosarcomapatientsbasedoninvitrocellculturemodelandanalysis
AT jiryouwang malignancyprogressionandtreatmentefficacyestimationofosteosarcomapatientsbasedoninvitrocellculturemodelandanalysis
AT weimingchen malignancyprogressionandtreatmentefficacyestimationofosteosarcomapatientsbasedoninvitrocellculturemodelandanalysis
AT yichungtung malignancyprogressionandtreatmentefficacyestimationofosteosarcomapatientsbasedoninvitrocellculturemodelandanalysis
AT yupingsu malignancyprogressionandtreatmentefficacyestimationofosteosarcomapatientsbasedoninvitrocellculturemodelandanalysis